In breast cancer, membrane immunohistochemical expression of PD-L2 by immune cells, detected with the monoclonal antibody (clone = D7U8C) from Cell Signaling Technology, was found almost negative, with these findings being confirmed also by flow cytometry data here, the monoclonal antibody. The gene discussed is PDCD1LG2; the disease is breast carcinoma.